Molecular assays for antimalarial drug resistance surveillance: a target product profile by Nsanzabana, C, Ariey, F, Beck, H, Ding, X, Kamau, E, Krishna, S, Legrand, E, Lucchi, N, Miotto, O, Nag, S, Noedl, H, Roper, C, Rosenthal, P, Schallig, H, Taylor, S, Volkman, S, Gonzalez, I

Defining the next generation of Plasmodium vivax diagnostic tests for control and elimination: Target product profiles by Ding, X, Ade, M, Baird, J, Cheng, Q, Cunningham, J, Dhorda, M, Drakeley, C, Felger, I, Gamboa, D, Harbers, M, Herrera, S, Lucchi, N, Mayor, A, Mueller, I, Sattabongkot, J, Ratsimbason, A, Richards, J, Tanner, M, González, I

Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial by Abreha, T, Hwang, J, Thriemer, K, Tadesse, Y, Girma, S, Melaku, Z, Assef, A, Kassa, M, Chatfield, M, Landman, K, Chenet, S, Lucchi, N, Udhayakumar, V, Zhou, Z, Shi, Y, Kachur, S, Jima, D, Kebede, A, Solomon, H, Mekasha, A, Alemayehu, B, Malone, J, Dissanayake, G, Teka, H, Auburn, S, von Seidlein, L, Price, R

The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density by Slater, HC, Ross, A, Felger, I, Hofmann, NE, Robinson, L, Cook, J, Gonçalves, BP, Björkman, A, Ouedraogo, AL, Morris, U, Msellem, M, Koepfli, C, Mueller, I, Tadesse, F, Gadisa, E, Das, S, Domingo, G, Kapulu, M, Midega, J, Owusu-Agyei, S, Nabet, C, Piarroux, R, Doumbo, O, Doumbo, SN, Koram, K, Lucchi, N, Udhayakumar, V, Mosha, J, Tiono, A, Chandramohan, D, Gosling, R, Mwingira, F, Sauerwein, R, Riley, EM, White, NJ, Nosten, F, Imwong, M, Bousema, T, Drakeley, C, Okell, LC